• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis.肝硬化患者的 30 天再入院率在很大程度上是不可预防的。
Am J Gastroenterol. 2024 Feb 1;119(2):287-296. doi: 10.14309/ajg.0000000000002455. Epub 2023 Sep 27.
2
Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.聚四氟乙烯覆膜支架与裸支架经颈静脉肝内门体分流术治疗肝硬化的效果比较。
Cochrane Database Syst Rev. 2023 Aug 2;8(8):CD012358. doi: 10.1002/14651858.CD012358.pub2.
3
Readmission Within 90 Days After Primary THA Is Associated With Decreased Improvement in 1-Year Patient-reported Outcome Measures and Increased Reoperation Rates.初次全髋关节置换术后90天内再次入院与患者报告的1年结局指标改善降低及再次手术率增加相关。
Clin Orthop Relat Res. 2025 Feb 27. doi: 10.1097/CORR.0000000000003429.
4
High Risk of Readmission After THA Regardless of Functional Status in Patients Discharged to Skilled Nursing Facility.入住专业护理机构的患者,无论功能状态如何,全髋关节置换术后再入院风险均高。
Clin Orthop Relat Res. 2024 Jul 1;482(7):1185-1192. doi: 10.1097/CORR.0000000000002950. Epub 2024 Jan 16.
5
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.L-鸟氨酸L-天冬氨酸用于预防和治疗肝硬化患者的肝性脑病。
Cochrane Database Syst Rev. 2018 May 15;5(5):CD012410. doi: 10.1002/14651858.CD012410.pub2.
6
Clinical service organisation for heart failure.心力衰竭的临床服务组织
Cochrane Database Syst Rev. 2012 Sep 12(9):CD002752. doi: 10.1002/14651858.CD002752.pub3.
7
Nutritional support for liver disease.肝病的营养支持
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008344. doi: 10.1002/14651858.CD008344.pub2.
8
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis.利福昔明预防和治疗肝硬化患者肝性脑病。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD011585. doi: 10.1002/14651858.CD011585.pub2.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients With Cirrhosis and Ascites: A Systematic Review and Meta-Analysis.早期诊断性腹腔穿刺术改善肝硬化并腹水住院患者的预后:系统评价和荟萃分析。
Am J Gastroenterol. 2024 Nov 1;119(11):2259-2266. doi: 10.14309/ajg.0000000000002906. Epub 2024 Jun 25.

引用本文的文献

1
A Comprehensive Evaluation of Emergency Department Utilization by Patients With Cirrhosis.肝硬化患者急诊科利用情况的综合评估
Am J Gastroenterol. 2024 Dec 1;119(12):2444-2454. doi: 10.14309/ajg.0000000000002905. Epub 2024 Jun 24.

本文引用的文献

1
Measuring Medication Use, Obstacles, and Knowledge in Individuals With Cirrhosis.测量肝硬化患者的药物使用、障碍和知识。
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1819-1830.e5. doi: 10.1016/j.cgh.2022.08.025. Epub 2022 Aug 31.
2
Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle.实施失代偿期肝硬化出院综合护理方案后预后得到改善。
Frontline Gastroenterol. 2021 Dec 15;13(5):409-415. doi: 10.1136/flgastro-2021-102021. eCollection 2022.
3
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation.社区贫困与肝移植评估期间未能候补等待和死亡相关。
Liver Transpl. 2022 Sep;28(9):1441-1453. doi: 10.1002/lt.26473. Epub 2022 Jun 26.
4
Attendance at a Transitional Liver Clinic May Be Associated with Reduced Readmissions for Patients with Liver Disease.参加过渡性肝脏诊所可能与减少肝病患者的再入院率有关。
Am J Med. 2022 Feb;135(2):235-243.e2. doi: 10.1016/j.amjmed.2021.09.016. Epub 2021 Oct 14.
5
Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals.医学与科学期刊中种族与民族报告的更新指南。
JAMA. 2021 Aug 17;326(7):621-627. doi: 10.1001/jama.2021.13304.
6
Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis.患者报告的结局测量适度增强了对肝硬化患者再入院的预测。
Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1426-e1437. doi: 10.1016/j.cgh.2021.07.032. Epub 2021 Jul 24.
7
Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.机器学习对肝硬化再入院和死亡的预测能力较低。
Am J Gastroenterol. 2021 Feb 1;116(2):336-346. doi: 10.14309/ajg.0000000000000971.
8
Health-Related Quality of Life: A Rapid Predictor of Hospitalization in Patients With Cirrhosis.健康相关生活质量:肝硬化患者住院的快速预测指标。
Am J Gastroenterol. 2020 Apr;115(4):575-583. doi: 10.14309/ajg.0000000000000545.
9
How do studies assess the preventability of readmissions? A systematic review with narrative synthesis.研究如何评估再入院的可预防程度?系统评价与叙述性综合。
BMC Med Res Methodol. 2019 Jun 19;19(1):128. doi: 10.1186/s12874-019-0766-0.
10
Changes to Racial Disparities in Readmission Rates After Medicare's Hospital Readmissions Reduction Program Within Safety-Net and Non-Safety-Net Hospitals.医保医院再入院率削减计划实施后,医保安全网内和非安全网内医院入院率的种族差异变化。
JAMA Netw Open. 2018 Nov 2;1(7):e184154. doi: 10.1001/jamanetworkopen.2018.4154.

肝硬化患者的 30 天再入院率在很大程度上是不可预防的。

Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis.

机构信息

Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas USA.

出版信息

Am J Gastroenterol. 2024 Feb 1;119(2):287-296. doi: 10.14309/ajg.0000000000002455. Epub 2023 Sep 27.

DOI:10.14309/ajg.0000000000002455
PMID:37543729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10873127/
Abstract

INTRODUCTION

Hospital readmissions are common in patients with cirrhosis, but there are few studies describing readmission preventability. We aimed to describe the incidence, causes, and risk factors for preventable readmission in this population.

METHODS

We performed a prospective cohort study of patients with cirrhosis hospitalized at a single center between June 2014 and March 2020 and followed up for 30 days postdischarge. Demographic, clinical, and socioeconomic data, functional status, and quality of life were collected. Readmission preventability was independently and systematically adjudicated by 3 reviewers. Multinomial logistic regression was used to compare those with (i) preventable readmission, (ii) nonpreventable readmission/death, and (iii) no readmission.

RESULTS

Of 654 patients, 246 (38%) were readmitted, and 29 (12%) were preventable readmissions. Reviewers agreed on preventability for 70% of readmissions. Twenty-two (including 2 with preventable readmission) died. The most common reasons for readmission were hepatic encephalopathy (22%), gastrointestinal bleeding (13%), acute kidney injury (13%), and ascites (6%), and these reasons were similar between preventable and nonpreventable readmissions. Preventable readmission was often related to paracentesis timeliness, diuretic adjustment monitoring, and hepatic encephalopathy treatment. Compared with nonreadmitted patients, preventable readmission was independently associated with racial and ethnic minoritized individuals (odds ratio [OR] 5.80; 95% CI, 1.96-17.13), nonmarried marital status (OR 2.88; 95% CI, 1.18-7.05), and admission in the prior 30 days (OR 3.45; 95% CI, 1.48-8.04).

DISCUSSION

For patients with cirrhosis, readmission is common, but most are not preventable. Preventable readmissions are often related to ascites and hepatic encephalopathy and are associated with racial and ethnic minorities, nonmarried status, and prior admissions.

摘要

简介

肝硬化患者的住院再入院较为常见,但很少有研究描述其可预防性。本研究旨在描述该人群中再入院的发生率、原因和可预防性因素。

方法

我们对 2014 年 6 月至 2020 年 3 月期间在单中心住院的肝硬化患者进行了前瞻性队列研究,并在出院后 30 天进行了随访。收集了人口统计学、临床和社会经济数据、功能状态和生活质量。再入院的可预防性由 3 名评审员进行独立和系统的裁定。多分类逻辑回归用于比较(i)可预防性再入院、(ii)非可预防性再入院/死亡和(iii)无再入院患者。

结果

654 例患者中,246 例(38%)再入院,29 例(12%)为可预防性再入院。评审员对 70%的再入院达成了可预防性的一致意见。22 例患者死亡(包括 2 例可预防性再入院患者)。再入院的最常见原因是肝性脑病(22%)、胃肠道出血(13%)、急性肾损伤(13%)和腹水(6%),这些原因在可预防性和非可预防性再入院中相似。可预防性再入院常与放腹水的及时性、利尿剂调整监测和肝性脑病治疗有关。与未再入院患者相比,可预防性再入院与种族和民族少数人群(比值比[OR] 5.80;95%置信区间[CI],1.96-17.13)、非已婚婚姻状况(OR 2.88;95%CI,1.18-7.05)和入院前 30 天(OR 3.45;95%CI,1.48-8.04)相关。

讨论

对于肝硬化患者,再入院很常见,但大多数是不可预防的。可预防性再入院通常与腹水和肝性脑病有关,与少数民族、非已婚状态和既往入院有关。